Mirko Beljanski

1.4k total citations · 1 hit paper
51 papers, 994 citations indexed

About

Mirko Beljanski is a scholar working on Molecular Biology, Oncology and Plant Science. According to data from OpenAlex, Mirko Beljanski has authored 51 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Plant Science. Recurrent topics in Mirko Beljanski's work include RNA and protein synthesis mechanisms (11 papers), Cancer therapeutics and mechanisms (7 papers) and DNA and Nucleic Acid Chemistry (7 papers). Mirko Beljanski is often cited by papers focused on RNA and protein synthesis mechanisms (11 papers), Cancer therapeutics and mechanisms (7 papers) and DNA and Nucleic Acid Chemistry (7 papers). Mirko Beljanski collaborates with scholars based in France, United States and Switzerland. Mirko Beljanski's co-authors include Philippe Anker, P Maurice, Maurice Stroun, C Lederrey, Jacqueline Lyautey, Sylvain Crochet, P Bourgarel, Severo Ochoa, Mukti Ojha and P Manigault and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemical and Biophysical Research Communications and European Journal of Biochemistry.

In The Last Decade

Mirko Beljanski

45 papers receiving 943 citations

Hit Papers

Neoplastic Characteristics of the DNA Found in the Plasma... 1989 2026 2001 2013 1989 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mirko Beljanski France 10 596 511 257 168 160 51 994
Raquel Ciuvalschi Maia Brazil 23 765 1.3× 185 0.4× 555 2.2× 62 0.4× 199 1.2× 96 1.5k
Lela Buckingham United States 17 505 0.8× 122 0.2× 353 1.4× 175 1.0× 49 0.3× 48 983
Michael H.L. Green United Kingdom 12 447 0.8× 298 0.6× 112 0.4× 54 0.3× 41 0.3× 14 755
G.P. Margison United Kingdom 19 992 1.7× 470 0.9× 178 0.7× 28 0.2× 61 0.4× 39 1.2k
Peter H. Clingen United Kingdom 13 690 1.2× 245 0.5× 223 0.9× 128 0.8× 69 0.4× 17 990
T C Hamilton United States 10 431 0.7× 122 0.2× 314 1.2× 38 0.2× 96 0.6× 14 781
Wayne D. Klohs United States 16 456 0.8× 89 0.2× 249 1.0× 59 0.4× 38 0.2× 33 728
Nancy Matheson United States 14 313 0.5× 318 0.6× 117 0.5× 176 1.0× 20 0.1× 18 1.0k
Arlene R. Cashmore United States 22 721 1.2× 61 0.1× 243 0.9× 103 0.6× 40 0.3× 35 1.3k
Chaoxin Hu United States 13 434 0.7× 128 0.3× 367 1.4× 47 0.3× 81 0.5× 18 920

Countries citing papers authored by Mirko Beljanski

Since Specialization
Citations

This map shows the geographic impact of Mirko Beljanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirko Beljanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirko Beljanski more than expected).

Fields of papers citing papers by Mirko Beljanski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirko Beljanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirko Beljanski. The network helps show where Mirko Beljanski may publish in the future.

Co-authorship network of co-authors of Mirko Beljanski

This figure shows the co-authorship network connecting the top 25 collaborators of Mirko Beljanski. A scholar is included among the top collaborators of Mirko Beljanski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirko Beljanski. Mirko Beljanski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beljanski, Mirko. (2013). The Regulation of DNA Replication and Transcription. 2 indexed citations
2.
Beljanski, Mirko. (1996). De Novo synthesis of DNA-like molecules by polynucleotide phosphorylase in vitro. Journal of Molecular Evolution. 42(5). 493–499. 11 indexed citations
3.
Beljanski, Mirko & Sylvain Crochet. (1994). THE SELECTIVE ANTICANCER AGENT PB-100 INHIBITS INTERLEUKIN-6 INDUCED ENHANCEMENT OF GLIOBLASTOMA CELL-PROLIFERATION IN-VITRO. International Journal of Oncology. 5(4). 873–9. 6 indexed citations
4.
Beljanski, Mirko & Sylvain Crochet. (1994). Differential effects of ferritin, calcium, zinc, and gallic acid on in vitro proliferation of human glioblastoma cells and normal astrocytes.. PubMed. 123(4). 547–55. 10 indexed citations
5.
Stroun, Maurice, Philippe Anker, P Maurice, et al.. (1989). Neoplastic Characteristics of the DNA Found in the Plasma of Cancer Patients. Oncology. 46(5). 318–322. 585 indexed citations breakdown →
6.
Beljanski, Mirko & S. K. Dutta. (1987). Differential Synthesis and Replication of DNA in the <i>Neurospora crassa</i> Slime Mutant versus Normal Cells: Role of Carcinogens. Oncology. 44(5). 327–330. 1 indexed citations
7.
Beljanski, Mirko. (1983). The Regulation of DNA Replication and Transcription: The Role of Trigger Molecules in Normal and Malignant Gene Expression. Medical Entomology and Zoology. 1 indexed citations
8.
Beljanski, Mirko, et al.. (1982). In vitro Screening of Carcinogens Using DNA of the His<sup>-</sup>Mutant of <i>Salmonella typhimurium</i>. Pathobiology. 50(5). 271–280. 2 indexed citations
9.
Beljanski, Mirko, et al.. (1981). Correlation between in vitro DNA Synthesis, DNA Strand Separation and in vivo Multiplication of Cancer Cells. Pathobiology. 49(4). 220–231. 5 indexed citations
10.
Beljanski, Mirko, et al.. (1976). Particular small size RNA and RNA fragments from different origins as tumor inducing agents in Datura stramonium. Molecular Biology Reports. 2(6). 497–506.
11.
Beljanski, Mirko, et al.. (1975). [RNA fragments, in vivo inhibitors of Shope fibroma and vaccinia virus multiplication].. PubMed. 280(6). 783–9. 1 indexed citations
12.
Beljanski, Mirko, et al.. (1974). RNA-bound reverse transcriptase in Escherichia coli and in vitro synthesis of a complementary DNA. Biochemical Genetics. 12(2). 163–180. 7 indexed citations
13.
Beljanski, Mirko. (1973). [Separation of reverse transcriptase from DNA-dependant DNA polymerase. Analysis of DNA synthetized on the model of RNA transformans].. PubMed. 276(10). 1625–8. 1 indexed citations
14.
Beljanski, Mirko & P Bourgarel. (1971). [RNA episome carried by the DNA of wild and showdomycin-resistant Escherichia coli].. PubMed. 272(21). 2736–9. 2 indexed citations
15.
Beljanski, Mirko, et al.. (1971). Drastic Alteration of Ribosomal RNA and Ribosomal Proteins in Showdomycin-Resistant Escherichia coli. Proceedings of the National Academy of Sciences. 68(2). 491–495. 5 indexed citations
16.
Beljanski, Mirko & P Bourgarel. (1971). [Transforming RNA bearers of hereditary characters in showdomycino-resistant Escherichia coli].. PubMed. 272(16). 2107–10. 3 indexed citations
17.
Beljanski, Mirko, et al.. (1970). [Showdomycin and biosynthesis of RNA non complementary to DNA. I].. PubMed. 118(3). 253–76. 4 indexed citations
18.
Beljanski, Mirko, et al.. (1968). [Synthesis in Escherichia coli of RNA whose primary structure differs entirely from that of DNA].. PubMed. 267(12). 1058–60. 3 indexed citations
20.
Beljanski, Mirko & Severo Ochoa. (1958). PROTEIN BIOSYNTHESIS BY A CELL-FREE BACTERIAL SYSTEM. Proceedings of the National Academy of Sciences. 44(6). 494–501. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026